Advertisement

Topics

Janssen's Tremfya (guselkumab) Makes its Debut in the Psoriasis Market and Early Dermatologist ...

16:55 EDT 9 Aug 2017 | BioMedReports - Blog

Possible barriers to rapid uptake will come in the form of differentiation from the existing biologics, namely Janssen's own Stelara, as well as from the

Read more...

Original Article: Janssen's Tremfya (guselkumab) Makes its Debut in the Psoriasis Market and Early Dermatologist ...

NEXT ARTICLE

More From BioPortfolio on "Janssen's Tremfya (guselkumab) Makes its Debut in the Psoriasis Market and Early Dermatologist ..."

Quick Search
Advertisement
 

Relevant Topic

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...